Acrivon Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	35.41	39.82	36.02	29.52	99.6	1.58
Short-Term Investments	93.85	139.66	91.44	98.23	-	-
Cash & Short-Term Investments	129.25	179.48	127.46	127.75	99.6	1.58
Cash Growth	-31.05%	40.81%	-0.23%	28.26%	6192.04%	-
Prepaid Expenses	1.11	2.15	2.23	4.34	0.81	0.14
Total Current Assets	130.36	181.63	129.69	132.1	100.41	1.72
Property, Plant & Equipment	7.98	8.03	7.91	6.86	5.79	0.06
Long-Term Investments	5.11	5.09	-	41.88	-	-
Long-Term Deferred Charges	-	0.5	-	-	-	-
Other Long-Term Assets	1.85	1.35	0.67	0.39	0.39	0.41
Total Assets	145.3	196.59	138.27	181.23	106.59	2.19
Accounts Payable	1	0.76	5.05	0.9	0.96	0.14
Accrued Expenses	12.71	15.4	7.38	4.14	1.22	0.42
Short-Term Debt	-	-	-	-	-	0.06
Current Portion of Leases	1.18	1.06	0.88	0.73	0.66	-
Current Unearned Revenue	-	-	-	0.07	0.07	-
Other Current Liabilities	-	-	-	0.67	-	-
Total Current Liabilities	14.89	17.21	13.3	6.52	2.91	0.61
Long-Term Leases	1.81	2.59	3.77	4.24	4.96	-
Total Liabilities	16.7	19.8	17.07	10.75	7.88	0.61
Common Stock	0.03	0.03	0.02	0.02	0	0
Additional Paid-In Capital	384.36	373.28	237.68	226.58	1.05	0.21
Retained Earnings	-255.9	-196.98	-116.42	-56.03	-24.87	-8.62
Comprehensive Income & Other	0.11	0.45	-0.08	-0.1	-	-
Total Common Equity	128.6	176.79	121.2	170.48	-23.81	-8.41
Shareholders' Equity	128.6	176.79	121.2	170.48	98.71	1.57
Total Liabilities & Equity	145.3	196.59	138.27	181.23	106.59	2.19
Total Debt	2.99	3.65	4.64	4.96	5.63	0.06
Net Cash (Debt)	126.27	175.84	122.81	122.79	93.98	1.53
Net Cash Growth	-31.17%	43.17%	0.02%	30.66%	6062.30%	-
Net Cash Per Share	3.29	5.20	5.56	29.79	53.90	1.06
Filing Date Shares Outstanding	31.56	31.35	22.64	21.92	1.77	1.43
Total Common Shares Outstanding	31.55	31.23	22.52	21.92	1.77	1.43
Working Capital	115.47	164.42	116.39	125.58	97.49	1.11
Book Value Per Share	4.08	5.66	5.38	7.78	-13.45	-5.87
Tangible Book Value	128.6	176.79	121.2	170.48	-23.81	-8.41
Tangible Book Value Per Share	4.08	5.66	5.38	7.78	-13.45	-5.87
Machinery	6.9	6.38	3.13	2.51	0.35	0.08
Construction In Progress	1.24	0.06	1.31	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q